HIV-related pulmonary hypertension

Mount Sinai Journal of Medicine

Volumn 73, Issue 7, 2006, Pages 1037-1044

  Limsukon, Atikun ^a,b,d   Saeed, Ali Imran ^a,b   Ramasamy, Vimala ^c   Nalamati, Jhansi ^c   Dhuper, Sunil ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

AIDS related pulmonary disease; Epoprostenol; Highly active antiretroviral therapy; HIV related pulmonary hypertension; Pulmonary hypertension

Indexed keywords

ANTICOAGULANT AGENT; ANTIRETROVIRUS AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SILDENAFIL;

ARTICLE; CARDIOMEGALY; CONTINUOUS INFUSION; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG FATALITY; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; FATIGUE; FLUSHING; FOOT EDEMA; HEADACHE; HEALTH CARE AVAILABILITY; HEART CATHETERIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; JAW DISEASE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MORTALITY; PREVALENCE; PROBABILITY; PROGNOSIS; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIDE EFFECT; SURVIVAL RATE; SYMPTOM; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TACHYPHYLAXIS; THORAX PAIN; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; PROGNOSIS; PULMONARY ARTERY; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS;

EID: 33845987400     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kim KK, Factor SM. Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome. Hum Pathol 1987; 18(12):1293-1296.
2. Speich R, Jenni R, Opravil M, et al. Primary pulmonary hypertension in HIV infection. Chest 1991; 100:1268-1271.
3. Polos PG, Wolfe D, Harley RA, et al. Pulmonary hypertension and human immunodeficiency virus infection. Two reports and a review of the literature. Chest 1992; 101:474-478.
4. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 1998; 73:37-45.
5. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 2000; 118:1133-1141.
6. Goldsmith GH Jr, Baily RG, Brettler DB, et al. Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med 1988; 108:797-799.
7. Mette SA, Palevsky HI, Pietra GG, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992; 145:1196-1200.
8. Humbert M, Monti G, Fartoukh M. et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 1998; 11:554-559.
9. Ehrenreich H, Rieckmann P, Sinowatz F, et al. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Inummol 1993; 150(10):4601-4609.
10. Opravil M, Pechere M, Speich R, et al. HIV-associated primary pulmonary hypertension. A case control study. Am J Respir Crit Care Med 1997; 155:990-995.
11. Nunes H, Humbert M, Sithon O, et al. Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003; 167(10):1433-1439.
12. Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician 2001; 63(9):1789-1798.
13. Stricker H, Domenighetti G, Mombelli G. Prostacyclin for HIV-associated pulmonary hypertension [letter]. Ann Intern Med 1997; 127:1043.
14. Aguilar RV, Farber HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care 2000; 162:1846-1850.
15. Ghofrani HA, Friese G, Discher T, et al. Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension. Eur Respir J 2004; 23(2):321-326.
16. Alp S, Schlottmann R, Bauer TT, et al. Long-time survival with HIV-related pulmonary arterial hypertension: a case report. AIDS 2003; 17(11):1714-1715.
17. Schumacher YO, Zdebik A, Huonker M, Kreisel W. Sildenafil in HIV-related pulmonary hypertension. AIDS 2001; 15:1747-1748.
18. Carlsen J, Kjeldsen K, Gerstoft J. Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension. AIDS 2002; 16:1568-1569.
19. Bray GL, Martin GR, Chandra R. Idiopathic pulmonary hypertension, hemophilia A, and infection with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111:689-690.
20. Legoux B, Piette AM, Bouchet PF, et al. Pulmonary hypertension and HIV infection. Am J Med 1990; 89(1):122.
21. Himelman RB, Dohrmann M, Goodman P, et al. Severe pulmonary hypertension and cor pulmonale in the acquired immurfodeficiency syndrome. Am J Cardiol 1989; 64:1396-1399.
22. Coplan NL, Shimony RY, Ioachim HL, et al. Primary pulmonary hypertension associated with human immunodeficiency viral infection. Am J Med 1990; 89:96-99.
23. Mani S, Smith GJW. HIV and pulmonary hypertension: a review. South Med J 1994; 87:357-362.
24. Weiss JR, Pietra GG, Schaft SM. Primary pulmonary hypertension and the human immunodeficiency virus: report of two cases and a review of the literature. Arch Intern Med 1995; 155:2350-2354.
25. Pellicelli AM, Palmieri F, D'Ambrosio C, et al. Role of human immunodeficiency virus in primary pulmonary hypertension. Angiology 1998; 49:1005-1011.
26. Recusani F, Di Matteo A, Gambarin F, et al. Clinical and therapeutical follow-up of HIV-associated pulmonary hypertension: prospective study of 10 patients. AIDS 2003; 17 (Suppl 1):S88-S95.
27. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIN patients: a systemic review. Angiology 2001; 52:31-41.
28. Morse JH, Barst RJ, Itescu S, et al. Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med 1996; 153(4 Pt 1):1299-1301.
29. Seoane L, Shellito J, Welsh D, de Boisblanc BP. Pulmonary hypertension associated with HIV infection. South Med J 2001; 94(6):635-639.
30. Bugnone AN, Viamonte M Jr., Garcia H. Imaging findings in human immunodeficiency virus-related pulmonary hypertension: report of five cases and review of the literature. Radiology 2002; 223(3):820-827.
31. Louis M, Thorens JB, Chevrolet JC: Calcium channel blockers, testing for primary pulmonary hypertension associated with HTV infection. Am Rev Respir Dis 1993; 147:536A.
32. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346(12):896-903.
33. Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170:1212-1217.
34. Pugliese A, Isnardi D, Saini A, et al. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000; 40:282-284.
35. Zuber JP, Calmy A, Evison JM, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004; 38(8):1178-1185.